LNTH Q3 2017 Earnings — Lantheus Holdings, Inc. Revenue & Financial Results | Market Cap Arena

LNTHLantheus Holdings, Inc.

$5B

Q3 2017 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$80M+9.4% YoY

Gross Profit

$39M48.2% margin

Operating Income

$13M16.0% margin

Net Income

$9M10.7% margin

EPS (Diluted)

$0.22

QoQ Revenue Growth

-10.0%

Cash Flow

Operating Cash Flow

$16M

Free Cash Flow

$12M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$281M

Total Liabilities

$359M

Stockholders' Equity

-$78M

Cash & Equivalents

$68M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$80M	$73M	+9.4%
Gross Profit	$39M	$34M	+14.4%
Operating Income	$13M	$13M	+1.8%
Net Income	$9M	$4M	+102.0%

Revenue Segments

US Segment

$70M87%

International Segment

$10M13%